Financials disclosed in this offering
FY2022–FY2023 · hover for sourceThe fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Amendments to this offering
4 amendments- Aug 6, 2025
- Deadline Jul 31, 2025 → Dec 31, 2025
“Issuer is extending their offering to December 31, 2025.”
Form C/A on EDGAR ↗ - Apr 30, 2025No change to filed terms
“Issuer is submitted an updated Annual Report with updated 2024 financial statements.”
Form C/A on EDGAR ↗ - Apr 30, 2025
- Deadline Apr 25, 2025 → Jul 31, 2025
“Issuer will be extending their offering to July 31st, 2025.”
Form C/A on EDGAR ↗ - Mar 18, 2025
- Deadline Apr 1, 2025 → Apr 25, 2025
“Issuer will be extending their offering to April 25th, 2025.”
Form C/A on EDGAR ↗
Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.
Deal terms
Estimated, not stated: $1.50 × 84,221,532 securities outstanding as of Oct 27, 2023 (Form 1-A POS filed Oct 27, 2023).
Down round. Priced 40% below Reg A Offering (2022) (Dec 2022): $1.50 vs $2.50 a share in today's terms.
Offering details
Links & provenance
0001840495-24-000002
Last synced Sep 25, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.